Trials / Terminated
TerminatedNCT01163526
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 13 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A research study of liver perfusion (how blood flows to the liver over time). We hope to learn whether perfusion characteristics of liver masses may be predictive of response to treatment and whether liver perfusion characteristics can be used to follow response to treatment.
Conditions
- Neuroendocrine Tumors
- Brain (Nervous System) Cancers
- Colon/Rectal Cancer
- Colon Cancer
- Hepatobiliary Cancers
- Hepatocellular Carcinoma (Hepatoma)
- Liver
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | CT perfusion |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2010-07-15
- Last updated
- 2017-01-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01163526. Inclusion in this directory is not an endorsement.